Martti Antila

1.3k total citations
18 papers, 123 citations indexed

About

Martti Antila is a scholar working on Physiology, Immunology and Allergy and Dermatology. According to data from OpenAlex, Martti Antila has authored 18 papers receiving a total of 123 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 10 papers in Immunology and Allergy and 5 papers in Dermatology. Recurrent topics in Martti Antila's work include Asthma and respiratory diseases (11 papers), Allergic Rhinitis and Sensitization (8 papers) and Food Allergy and Anaphylaxis Research (4 papers). Martti Antila is often cited by papers focused on Asthma and respiratory diseases (11 papers), Allergic Rhinitis and Sensitization (8 papers) and Food Allergy and Anaphylaxis Research (4 papers). Martti Antila collaborates with scholars based in Brazil, United States and Spain. Martti Antila's co-authors include Fábio Fernandes Morato Castro, Joachim H. Ficker, Sinisa Savic, Michael P. Levine, Xu Shu, MeiLan K. Han, Maarten Beekman, Weihua Cao, Amparo López‐Bernús and И. Г. Гордеев and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Journal of the American Academy of Dermatology and British Journal of Dermatology.

In The Last Decade

Martti Antila

14 papers receiving 117 citations

Peers

Countries citing papers authored by Martti Antila

Since Specialization

Citations

This map shows the geographic impact of Martti Antila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martti Antila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martti Antila more than expected).

Fields of papers citing papers by Martti Antila

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martti Antila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martti Antila. The network helps show where Martti Antila may publish in the future.

Co-authorship network of co-authors of Martti Antila

This figure shows the co-authorship network connecting the top 25 collaborators of Martti Antila. A scholar is included among the top collaborators of Martti Antila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martti Antila. Martti Antila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Dupilumab Efficacy in Children With Type 2 Asthma Receiving High- to Medium-Dose Inhaled Corticosteroids (VOYAGE) 2024 ·The Journal of Allergy and Clinical Immunology In Practice ·Jorge Máspero, Martti Antila, A. Deschildre, Leonard B. Bacharier, Arman Altincatal, Elizabeth Laws, (unknown), Amr Radwan, Juby A. Jacob‐Nara, (unknown), Paul J. Rowe, David J. Lederer, Megan Hardin	3
2	Chronic urticaria treatment challenges in children. 2024 ·PubMed ·Luís Felipe Ensina, (unknown), (unknown), Martti Antila, Moshe Ben‐Shoshan, Dirceu Solé	0
3	43740 The Effect of Systemic Treatment on Different Anatomical Regions in Pediatric Patients with Atopic Dermatitis: Real-World Data from PEDISTAD 2023 ·Journal of the American Academy of Dermatology ·Danielle Marcoux, Michele Ramien, Martti Antila, Nelson Augusto Rosário Filho, Lara Wine Lee, (unknown), Joel C. Joyce, Rajan Gupta, Marius Ardeleanu, Annie Zhang	0
4	SARS-CoV-2-neutralising antibody BGB-DXP593 in mild-to-moderate COVID-19: a multicentre, randomised, double-blind, phase 2 trial 2023 ·EClinicalMedicine ·(unknown), Martti Antila, Carlos A. Pérez, (unknown), (unknown), Wei Zhang, (unknown), Zhen Yao, John E.J. Rasko	3
5	347 The real-world burden of atopic dermatitis: MEASURE-AD multicountry study results from Brazil, Mexico and Argentina 2023 ·British Journal of Dermatology ·Roberta Fachini Jardim Criado, (unknown), (unknown), Tânia Ferreira Cestari, Jorge Máspero, Paula Carolina Luna, (unknown), Martti Antila	2
6	Practical guide for the use of immunobiologic agents in allergic diseases - ASBAI 2023 ·(unknown), Norma de Paula Motta Rubini, (unknown), (unknown), (unknown), Faradiba Sarquis Serpa, (unknown), Martti Antila, (unknown), Rosana Câmara Agondi, (unknown), Régis A. Campos, Ekaterini Goudouris, Fábio Chigres Kuschnir, (unknown), Nelson Augusto Rosário Filho	0
7	Prevalence of the eosinophilic phenotype among severe asthma patients in Brazil: the BRAEOS study 2022 ·Jornal Brasileiro de Pneumologia ·Rodrigo Abensur Athanazio, Rafaël Stelmach, Martti Antila, Adelmir Souza‐Machado, L. Karla Arruda, Alcindo Cerci Neto, Faradiba Sarquis Serpa, Daniela Cavalet Blanco, Marina Andrade Lima, Pedro Giavina‐Bianchi, (unknown), Marcelo Fouad Rabahi	4
8	Disease characteristics, comorbidities, treatment patterns and quality of life impact in children <12 years old with atopic dermatitis: Interim results from the PEDISTAD Real-World Registry 2022 ·Journal of the American Academy of Dermatology ·Amy S. Paller, Emma Guttman‐Yassky, Marie L. A. Schuttelaar, Alan D. Irvine, Eulàlia Baselga, Yoko Kataoka, Martti Antila, Marjolein de Bruin‐Weller, Danielle Marcoux, (unknown), E. Rizova, Chunyuan Liu, Annie Zhang	10
9	Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trial 2022 ·The Lancet Rheumatology ·MeiLan K. Han, Martti Antila, Joachim H. Ficker, И. Г. Гордеев, (unknown), Amparo López‐Bernús, Antoine Roquilly, José Sifuentes‐Osornio, Fehmı Tabak, Ricardo Teijeiro, (unknown), (unknown), Xu Shu, James M. Felser, Barbara Knorr, Weihua Cao, Peter Langmuir, Thomas Lehmann, Michael P. Levine, Sinisa Savic	32
10	Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline 2022 ·Respiratory Medicine ·Arnaud Bourdin, J. Christian Virchow, Alberto Papi, Njira Lugogo, Philip G. Bardin, Martti Antila, David Halpin, Nadia Daizadeh, Michel Djandji, Benjamin Ortiz, Juby A. Jacob‐Nara, (unknown), Yamo Deniz, Paul J. Rowe	6
11	Over-prescription of short-acting β ₂ -agonists is associated with poor asthma outcomes: results from the Latin American cohort of the SABINA III study 2022 ·Journal of Asthma ·(unknown), (unknown), (unknown), Martti Antila, (unknown), (unknown), (unknown), Maarten Beekman	17
12	Cross-sectional, observational study to estimate the prevalence of the eosinophilic phenotype for Brazilian patients with severe asthma: the BRAEOS study 2020 ·Rodrigo Abensur Athanazio, Rafaël Stelmach, Martti Antila, (unknown), L. Karla Arruda, Alcindo Cerci Neto, (unknown), (unknown), Marina Andrade Lima, Marcelo Fouad Rabahi, Pedro Giavina‐Bianchi, (unknown), (unknown), (unknown), (unknown), (unknown)	3
13	Mometasone furoate in the treatment of mild, moderate, or severe persistent allergic rhinitis: a non-inferiority study (PUMA) 2016 ·Brazilian Journal of Otorhinolaryngology ·Martti Antila, (unknown), (unknown), (unknown), Fátima Rodrigues Fernandes, Nelson Augusto Rosário Filho, Rafaël Stelmach	0
14	Futura study: evaluation of efficacy and safety of rupatadine fumarate in the treatment of persistent allergic rhinitis 2009 ·Brazilian Journal of Otorhinolaryngology ·Olavo Mion, Régis A. Campos, Martti Antila, Priscila Bogar Rapoport, Nelson Augusto Rosário Filho, João Ferreira de Mello, Roberto Eustáquio Santos Guimarães, Marcos Mocellin, (unknown), Dirceu Solé, (unknown), (unknown), (unknown)	7
15	FUTURA STUDY-Evaluation of efficacy and safety of rupatadine fumarate in the treatment of persistent allergic rhinitis 2009 ·Brazilian Journal of Otorhinolaryngology ·Olavo Mion, Régis A. Campos, Martti Antila, Priscila Bogar Rapoport, Nelson Augusto Rosário Filho, João Ferreira de Mello, Roberto Eustáquio Santos Guimarães, Marcos Mocellin, (unknown), Dirceu Solé, (unknown), (unknown), (unknown)	7
16	Rupatadine fumarate is effective in the treatment of persistent allergic rhinitis: A multicentre study 2007 ·Allergy ·Olavo Mion, João Ferreira de Mello, (unknown), (unknown), Marcos Mocellin, (unknown), (unknown), Martti Antila, Dirceu Solé, (unknown), (unknown), Aroldo Miniti	3
17	Occupational allergy caused by urticating hair of Brazilian spider 1995 ·Journal of Allergy and Clinical Immunology ·Fábio Fernandes Morato Castro, Martti Antila, (unknown)	18
18	Biochemical properties and study of antigenic cross-reactivity between Africanized honey bee and wasp venom. 1994 ·PubMed ·Fábio Fernandes Morato Castro, Mário Sérgio Palma, Márcia Regina Brochetto-Braga, Osmar Malaspina, (unknown), M. Antonietta Baldo, Martti Antila, (unknown), (unknown), (unknown)	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact